Fluoride toothpaste inventors from IU win posthumous fame
Joseph Muhler and William Nebergall will be inducted May 2 in Washington, D.C., along with 17 other inventors and innovators.
Joseph Muhler and William Nebergall will be inducted May 2 in Washington, D.C., along with 17 other inventors and innovators.
Analysts had predicted that Lartruvo could eventually ring up as much as $600 million in annual sales. Eli Lilly and Co. now says it will suspend promotion of the drug.
The Whitestown Plan Commission has approved plans for a seven-building senior living center northeast of Main Street and Central Boulevard. The vacant land once was earmarked for a similar facility by another developer.
The Catalyst Award recognizes companies that excel in addressing recruitment, development and advancement of women. Today, nearly half of Lilly's senior leadership is female, up from 20 percent four years ago.
The Indianapolis-based provider of health clinics for businesses has grown to 250 employees in 10 years. But it recently started looking for another owner.
Congress legalized the production and sale of industrial hemp and hemp derivatives, including CBD. But FDA Commissioner Scott Gottlieb has restated his agency’s stance that CBD is a drug ingredient and therefore illegal to add to food or health products without his agency’s approval.
The dispute between the world’s largest retail chain and the prominent pharmacy-benefits manager could roil the business of filling prescriptions.
The ringleader in one of the largest corporate-fraud cases in Indiana in recent years says his legal team at Barnes & Thornburg failed to disclose a “profound conflict of interest.
Indianapolis hospitals are among those in the state imposing restrictions on visitors to try to curb the spread of flu.
A prolonged shutdown could muddle Eli Lilly and Co.’s plan to unload its stake in Elanco Animal Health Inc., the unit it spun off last year, Lilly CEO Dave Ricks said.
Eli Lilly and Co. won’t put the price of its prescription drugs in television ads, as the Trump administration has called for pharmaceutical companies to do, but will begin promoting a website where prices are available.
Lower smoking rates are translating into fewer deaths. Advances in early detection and treatment also are having a positive impact, experts say.
A New Jersey-based company that acquired Cook Group’s drug-delivery technology unit in late 2017 has plans for a major expansion.
Drug industry analysts on Monday applauded Eli Lilly and Co.’s pending $8 billion cash deal to buy a startup that focuses on oncology, which has become a prime focus for the pharma giant in the last year.
Connecticut-based Loxo Oncology, which was founded in 2013 and went public a year later, has a cancer drug in development that recently received U.S. Food and Drug Administration "breakthrough therapy" status.
Bristol-Myers and Celgene combined will have nine products with more than $1 billion in annual sales and significant potential for growth in the core disease areas of oncology, immunology and cardiovascular disease.
The Indianapolis Parks Department is proposing the creation of public-private partnership involving a health care provider to help pay for a new family event center at Broad Ripple Park.
Pharmaceutical giants Merck & Co. and Pfizer Inc. were kings of the Dow Jones industrial index during the year, while Eli Lilly and Co. was among the 20 largest gainers on the S&P 500.
State Sen. John Ruckelshaus said too many new hospitals, especially in small wealthy clusters, might be driving up the cost of health care. He said his bill was prompted by a recent effort by St. Vincent to rezone a 30-acre site in Carmel.
Hyde Park Venture Partners Principal Tim Kopp, the former CMO of ExactTarget, and David Shank, CEO of Shank Public Relations Counselors, talk about the warnings from their doctors that led them to start eating healthier and exercising.